CVS Health Corp
NYSE:CVS

Watchlist Manager
CVS Health Corp Logo
CVS Health Corp
NYSE:CVS
Watchlist
Price: 58.01 USD 1.59% Market Closed
Market Cap: 73B USD
Have any thoughts about
CVS Health Corp?
Write Note

CVS Health Corp
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CVS Health Corp
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
CVS Health Corp
NYSE:CVS
Accounts Receivables
$9.9B
CAGR 3-Years
6%
CAGR 5-Years
-13%
CAGR 10-Years
-1%
DaVita Inc
NYSE:DVA
Accounts Receivables
$2.3B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
4%
Chemed Corp
NYSE:CHE
Accounts Receivables
$196.5m
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
4%
Quest Diagnostics Inc
NYSE:DGX
Accounts Receivables
$1.4B
CAGR 3-Years
-2%
CAGR 5-Years
4%
CAGR 10-Years
4%
Cigna Corp
NYSE:CI
Accounts Receivables
$27.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Accounts Receivables
$2.2B
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
10%
No Stocks Found

CVS Health Corp
Glance View

Market Cap
73B USD
Industry
Health Care

CVS Health Corp. embodies a pivotal role in the evolving healthcare landscape, blending retail pharmacy services with a robust healthcare system. Founded in 1963, CVS has transformed from a traditional pharmacy into a comprehensive health services provider, offering a myriad of solutions including pharmacy benefit management, retail clinics, and specialized health programs. The company’s strategic acquisitions, notably the purchase of Aetna in 2018, have positioned CVS to deliver integrated healthcare solutions that not only enhance patient care but also streamline costs. This diversified business model is designed to meet the growing demand for accessible and affordable healthcare, enabling CVS to capture a substantial share of the market while driving sustainable revenue growth. For investors, CVS Health represents an enticing opportunity, rooted in its fundamental strengths and forward-looking strategies. The company's ability to adapt to changing healthcare trends, such as the rise of telehealth and the increasing importance of preventative care, underscores its commitment to innovation. With a significant foothold in both retail and insurance sectors, CVS is uniquely positioned to capitalize on synergies that enhance profitability and customer satisfaction. Additionally, the company’s consistent focus on expense management and strategic investments in digital health technologies promise to fortify its competitive edge. As CVS Health continues to expand its services and improve operational efficiencies, investors can anticipate a resilient performance, making it a compelling consideration for those looking to invest in the future of healthcare.

CVS Intrinsic Value
147.57 USD
Undervaluation 61%
Intrinsic Value
Price

See Also

What is CVS Health Corp's Accounts Receivables?
Accounts Receivables
9.9B USD

Based on the financial report for Sep 30, 2024, CVS Health Corp's Accounts Receivables amounts to 9.9B USD.

What is CVS Health Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-1%

Over the last year, the Accounts Receivables growth was -5%. The average annual Accounts Receivables growth rates for CVS Health Corp have been 6% over the past three years , -13% over the past five years , and -1% over the past ten years .

Back to Top